IP Library Granted Patent US 10,670,581
Granted Patent B2
US 10,670,581 · App. 15/914,293 · Granted Jun 2, 2020

Nanobubbles

Inventors: Joseph Irudayaraj (Champaign, IL); Pushpak Bhandari (Lafayette, IN)
Assignee: Purdue Research Foundation
G01N33/5008A61K9/5047A61K31/407A61K41/00A61K41/0028A61K47/54A61K47/61A61K47/6925A61K49/223A61M37/0092A61P35/00G01N21/31A61M2210/1085G01N21/6428G01N21/6456G01N2021/6439
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,670,581
App. No.
15/914,293
Granted
Jun 2, 2020
Kind
B2
Abstract

The present invention provides oxygenized nanobubbles and their uses in imaging and cancer treatment when combined with therapeutic drugs and precise ultrasound beam steering.

Claims (14)

1. A method of using synthesized oxygen nanobubbles to observe intracellular dynamics of a single cell or single tissue, comprising:

a) providing synthesized oxygen nanobubbles (ONBs) each comprising a gaseous molecular oxygen core surrounded by a cellulosic polymer shell, wherein said core-shell structure is capable to force a light to deviate from its linear trajectory to generate light scattering, wherein the synthesized ONBs are sized between about 400 nm to about 800 nm, the cellulosic polymer shell comprises a reaction product of a crosslinker and carboxymethyl cellulose (CMC) material, and the crosslinker has a concentration of 0.1% to 1.0%, and the carboxymethyl cellulose (CMC) material has a concentration of 0.1% to 1.0%;

b) incubating said synthesized ONBs with target cells or tissue for a period of time, wherein each of said target cells has a nucleus; and

c) applying hyperspectral dark field microscopy to obtain precise location of said ONBs within said cells or tissue, wherein said location is determined by (i) reconstructing a hyperspectral image at a specific wavelength with signal normalization and setting of a spectral filter and intensity threshold; and (ii) locating the position in the reconstructed image and extracting a spectrum from hyperspectral data.

2. The method according to claim 1 , wherein the shell is about 20 nm in thickness and the gaseous core is about 350 nm diameter.

3. The method according to claim 1 , wherein the ONBs are monodisperse.

4. The method according to claim 1 , wherein the ONBs radiate light in all directions.

5. The method according to claim 1 , further comprising quantifying the ONBs within cellular organelles including a nucleus.

6. The method according to claim 1 , wherein said ONBs further encapsulate a therapeutic drug or a florescence imaging agent.

7. The method according to claim 1 is used to analyzing cellular uptake efficiency.

8. The method according to claim 1 , wherein the incubation time is about 1 hour to about 2 hours to observe cytoplasm ONBs, and about 2 hour to about 3 hours to observe sub-nucleus ONBs.

9. The method according to claim 1 , wherein the target cells are prostate cancer cells PC3 with 400 nm ONBs.

10. The method according to claim 1 , wherein the target tissue is mouse MB49 bladder cancer cell line.

11. The method of claim 1 , wherein the carboxymethyl cellulose (CMC) material comprises sodium carboxymethylcellulose, and the crosslinker comprises aluminum chloride.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2019
From: IRUDAYARAJ, JOSEPH MARIA KUMAR; BHANDARI, PUSHPAK N.
To: PURDUE RESEARCH FOUNDATION
Reel/Frame 050365/0567 →
CONFIRMATORY LICENSE Recorded May 25, 2018
From: PURDUE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046245/0960 →
Continuity (5)
Continuation In Part 14873208 · Oct 2, 2015
Provisional Application 62147267 · Apr 14, 2015
Provisional Application 62075496 · Nov 5, 2014
Provisional Application 62058793 · Oct 2, 2014
Related Publication 20180252702A1 · Sep 6, 2018